Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SK Biopharmaceuticals
Pharma
BMS JV sale, biotech debuts, possible deals—Fierce Pharma Asia
BMS is exiting a Chinese joint venture. Two biotechs have launched with Chinese assets. Roche and J&J are reportedly eyeing an ADC deal with Henlius.
Angus Liu
Sep 19, 2025 8:36am
SK eyes Xcopri expansion with phase 3 win in new seizure type
Sep 17, 2025 11:32am
Hengrui, Sanofi and Aslan—Fierce Pharma Asia
Jul 19, 2024 9:48am
SK Biotek earmarks $35M to expand its Irish API production plant
Jun 16, 2022 9:20am
Takeda, Merck, SK Biopharm and more—Fierce Pharma Asia
Nov 12, 2021 9:20am
BioNTech-Fosun, Samsung Biologics and more—Fierce Pharma Asia
Dec 18, 2020 9:15am
